I‐Chin Wu

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies

A robust cell culture system supporting the complete life cycle of hepatitis B virus

Inflammaging: a new immune–metabolic viewpoint for age-related diseases

Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health

Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B

Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma

Lipoprotein Receptors Redundantly Participate in Entry of Hepatitis C Virus

Chronic hepatitis B: Update 2009 #

Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism

Efficacy of Tenofovir Disoproxil Fumarate At 240 Weeks in Patients With Chronic Hepatitis B With High Baseline Viral Load

Hepatitis B virus variants

Hepatitis C Virus: 30 Years after Its Discovery

Chronic hepatitis C virus infection and lipoprotein metabolism

Antiretroviral Treatment of Adult HIV Infection

Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

Structure and Function of the Hepatitis C Virus Envelope Glycoproteins E1 and E2: Antiviral and Vaccine Targets

Hepatitis B reactivation during or after direct acting antiviral therapy – implication for susceptible individuals

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Sexually Transmitted Diseases Treatment Guidelines, 2010

A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1

Recommender systems survey

Recommender system based on workflow

Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection

Aberrant Serum Immunoglobulin G Glycosylation in Chronic Hepatitis B Is Associated With Histological Liver Damage and Reversible by Antiviral Therapy

Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic hepatitis B patients receiving oral antiviral agents

Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy‐proven histological damage†

Apolipoprotein J, a glucose-upregulated molecular chaperone, stabilizes core and NS5A to promote infectious hepatitis C virus virion production

Sustained Hepatitis B e Antigen Seroconversion in Patients with Chronic Hepatitis B after Adefovir Dipivoxil Treatment: Analysis of Precore and Basal Core Promoter Mutants

Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III

Collaborative relevance assessment for task-based knowledge support